SUVPF (SUVPF) Stock Price & Analysis
SUVPF (SUVPF) rose 0.00% to USD 288.22 as of June 10, 2026 at 03:28 UTC, according to Nexqual real-time market data.
SUVPF last closed at USD 288.22; the session ranged USD 233.92–233.92 on volume of 1 shares. Market capitalization is $19.90B, with a 52-week range of USD 208–312.93 (PNK). Source: Nexqual, June 10, 2026 at 03:28 UTC.
Key Statistics (as of June 10, 2026 at 03:28 UTC)
| Price | USD 288.22 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 288.22 |
| Open | USD 233.92 |
| Day Range | USD 233.92 – 233.92 |
| 52-Week Range | USD 208 – 312.93 |
| Volume | 1 shares |
| Market Cap | $19.90B |
| Exchange | PNK |
Technical Analysis (SUVPF)
Nexqual's technical model rates SUVPF "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 03:28 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 70.06 (overbought) |
| vs SMA50 | Above (USD 258.56) |
| MACD | 8.76 (positive) |
Analyst Ratings (SUVPF)
Wall Street analysts rate SUVPF "None", per Nexqual as of June 10, 2026 at 03:28 UTC.
| Consensus Rating | None |
|---|
Earnings (SUVPF)
| Revenue Estimate | $935.35M |
|---|
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Financials & Fundamentals (SUVPF)
| Total Revenue | $3.55B |
|---|---|
| Revenue Growth (YoY) | +1.80% |
| Gross Margin | +45.59% |
| Operating Margin | +17.11% |
| Profit Margin | +4.58% |
| ROE | +6.18% |
| Debt / Equity | 110.54 |
| Current Ratio | 0.91 |
| Total Cash | $573.80M |
| Total Debt | $4.30B |
| Free Cash Flow | $313.20M |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Financial Health Score (SUVPF)
Nexqual rates SUVPF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:28 UTC.
| Growth | Mixed — Revenue +4.7% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 46%, operating 17% |
| Balance Sheet | Weak — $574M cash vs $4.30B debt |
| Cash Flow | Solid — FCF $313M, 9% margin |
| Efficiency | Mixed — ROE 6%, ROA 3.7% |
Ownership (SUVPF)
| Insider Ownership | +25.61% |
|---|---|
| Institutional Ownership | +32.09% |
| Shares Outstanding | 34.81M |
| Float | 27.45M |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Leadership (SUVPF)
SUVPF is led by Michael Grosse (age 58), CEO & Chairman of the Executive Board, per Nexqual as of June 10, 2026 at 03:28 UTC.
| CEO & Chairman of the Executive Board | Michael Grosse (age 58) |
|---|---|
| CFO & Member of Executive Board | Florian Funck Dipl.Kfm. (age 54) |
| President of Sartorius North America | Maurice Phelan |
| President of Environmental Technology Division | Theo Thijssen |
Major Backers & Investors (SUVPF)
Notable institutional backers of SUVPF include Prudential World Fd., Inc.-PGIM Jennison Intl Opportunities Fd., Franklin Custodian Funds-FRANKLIN GROWTH FUND, T. Rowe Price, according to Nexqual as of June 10, 2026 at 03:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Prudential World Fd., Inc.-PGIM Jennison Intl Opportunities Fd. | 1.38% |
| Franklin Custodian Funds-FRANKLIN GROWTH FUND | 1.21% |
| T. Rowe Price | 1.08% |
| Baillie Gifford | 0.54% |
| Fidelity | 0.45% |
| -Price (T.Rowe) New Horizons Trust | 0.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 4.35% |
| BlackRock | 0.5% |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SDMHF | Sartorius Stedim Biotech | USD 212.25 | ▲ 0.59% |
| SARTF | Sartorius AG | USD 217.65 | ▲ 0% |
| CLPBF | COLOPLAST | USD 65.16 | ▲ 13.05% |
| TRUMF | TERUMO CORP | USD 13.6 | ▼ 9.09% |
| RYLPF | Koninklijke Philips N.V | USD 26.73 | ▲ 2.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:28 UTC. This page is informational and not investment advice.